Cargando…
Inclusion of Lactobacillus Reuteri in the Treatment of Helicobacter pylori in Sardinian Patients: A Case Report Series
Clinical studies have shown that bismuth-containing quadruple therapy given twice a day for 10 to 14 days is effective and safe in the treatment of Helicobacter pylori infection in Sardinia. However, bismuth is no longer available in Italy. To report the effectiveness and tolerability of pantoprazol...
Autores principales: | Dore, Maria P., Soro, Sara, Rocchi, Chiara, Loria, Maria F., Bibbò, Stefano, Pes, Giovanni M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839865/ https://www.ncbi.nlm.nih.gov/pubmed/27082621 http://dx.doi.org/10.1097/MD.0000000000003411 |
Ejemplares similares
-
G6PD Deficiency Does Not Enhance Susceptibility for Acquiring Helicobacter pylori Infection in Sardinian Patients
por: Dore, Maria Pina, et al.
Publicado: (2016) -
Metagenomic Changes of Gut Microbiota following Treatment of Helicobacter pylori Infection with a Simplified Low-Dose Quadruple Therapy with Bismuth or Lactobacillus reuteri
por: Dore, Maria Pina, et al.
Publicado: (2022) -
Role of Probiotics in Helicobacter pylori Eradication: Lessons from a Study of Lactobacillus reuteri Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump Inhibitor
por: Dore, Maria Pina, et al.
Publicado: (2019) -
Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy
por: Ojetti, Veronica, et al.
Publicado: (2012) -
What Is New in Helicobacter pylori Diagnosis. An Overview
por: Dore, Maria Pina, et al.
Publicado: (2021)